VP
venBio Partners LLC
SAN FRANCISCO CA · SEC CIK 0001776382
$519.38M2026Q2 reported value
7Positions
100.0%Top 10 weight · largest 30.9%
1 / 1New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
ACHV New+$38.62M
PHVS Added+$142,677
2026Q2 top sells estimated at quarter-end value
ARTV Sold out-$3.42M
HRMY Reduced-$618,970
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| PHVS | PHARVARIS N V | $160.57M | 30.92% | 4,643,430 | 4,126 | 0.1% | $142,677 | Added |
| PBLS | PARABILIS MEDICINES INC | $144.15M | 27.75% | 5,266,697 | 5,266,697 | — | — | First reported |
| ALMS | ALUMIS INC | $127.43M | 24.53% | 4,528,408 | 0 | 0.0% | — | Unchanged |
| ACHV | ACHIEVE LIFE SCIENCE INC | $38.62M | 7.44% | 5,914,720 | 5,914,720 | — | $38.62M | New |
| ALXO | ALX ONCOLOGY HLDGS INC | $26.67M | 5.14% | 12,884,638 | 0 | 0.0% | — | Unchanged |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $17.19M | 3.31% | 472,194 | -17,000 | -3.5% | -$618,970 | Reduced |
| LYEL | LYELL IMMUNOPHARMA INC | $4.74M | 0.91% | 337,697 | 0 | 0.0% | — | Unchanged |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $0 | 0.00% | 0 | -531,337 | -100.0% | -$3.42M | Sold out |